Comparative analysis and clinical value of the expression of metalloproteases and their inhibitors by intratumour stromal mononuclear inflammatory cells and those at the invasive front of breast carcinomas
Authors:
- Salomé González-ReyesSGSalomé González-Reyes
- Laura MarínLMLaura Marín
- Lucía GonzálezLGLucía González
- José M GonzálezJGJosé M González
- Maria L LamelasMLMaria L Lamelas
- Antonio M MerinoAMAntonio M Merino
- Elena RodríguezERElena Rodríguez
- Iván PidalIPIván Pidal
- José M Del CasarJCJosé M Del Casar
- Alejandro AndicoecheaAAAlejandro Andicoechea
- Francisco VizosoFVFrancisco Vizoso
- 17 December 2010
- journal article
- Published by Wiley in Histopathology
- Vol. 57 (6) , 862-876
Abstract
González L O, González‐Reyes S, Marín L, González L, González J M, Lamelas M L, Merino A M, Rodríguez E, Pidal I, del Casar J M, Andicoechea A & Vizoso F (2010) Histopathology57, 862–876 Comparative analysis and clinical value of the expression of metalloproteases and their inhibitors by intratumour stromal mononuclear inflammatory cells and those at the invasive front of breast carcinomas Aims: Matrix metalloproteases (MMPs) and their inhibitors (TIMPs) play an essential role in the degradation of stromal connective tissue and basement membrane components. The aim of this study was to determine whether the dynamic analysis of these components can help to predict tumour aggressiveness.Methods and results: An immunohistochemical study was performed using tissue arrays and specific antibodies against MMPs ‐1, ‐2, ‐7, ‐9, ‐11, ‐13 and ‐14 and TIMPs ‐1, ‐2 and ‐3. More than 5000 determinations on cancer specimens from 124 patients with invasive breast cancer were performed on the tumour centre core as well as on the invasive front. Immunostaining for MMPs/TIMPs on mononuclear inflammatory cells (MICs) was evaluated. To identify specific groups of tumours with distinct expression profiles, data obtained from both MICs populations were analysed by unsupervised hierarchical cluster analysis. When compared with MICs at the invasive front, intratumour MICs more frequently showed expression of MMP‐7 and ‐1 and TIMP‐3, but less frequently expression of MMP‐9 and ‐11 and TIMP‐2.Conclusions: Our data led us to consider the need of further studies in order to identify subsets of MICs and other protein elements of the microenvironment as attractive targets for new therapeutic strategies against cancer.Keywords
This publication has 34 references indexed in Scilit:
- Overexpression of matrix metalloproteinases and their inhibitors in mononuclear inflammatory cells in breast cancer correlates with metastasis-relapseBritish Journal of Cancer, 2007
- Decreased number of mast cells infiltrating into needle biopsy specimens leads to a better prognosis of prostate cancerBritish Journal of Cancer, 2007
- Study of matrix metalloproteinases and their inhibitors in breast cancerBritish Journal of Cancer, 2007
- Prognostic markers in triple‐negative breast cancerCancer, 2006
- Calcium channel α2δ1 subunit mediates spinal hyperexcitability in pain modulationPain, 2006
- Noise exposure and children’s blood pressure and heart rate: the RANCH projectOccupational and Environmental Medicine, 2006
- Inflammation and cancerNature, 2002
- Complex roles of tissue inhibitors of metalloproteinases in cancerOncogene, 2002
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002
- The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapiesThe Journal of Pathology, 2002